Pharming: Pharming receives positive recommendation from NICE for Joenja to treat APDS in adult and paediatric patients 12 years of age and older

Pharming Group N.V. (Pharming), a global biopharmaceutical company, announces that the National Institute for Health and Care Excellence (NICE) has issued positive final guidance recommending Joenja